Theranostics: Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? (Adv. Healthcare Mater. 6/2017),Advanced Healthcare Materials

当前位置： X-MOL 学术 › Adv. Healthcare Mater. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Theranostics: Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? (Adv. Healthcare Mater. 6/2017)
Advanced Healthcare Materials ( IF 10.0 ) Pub Date : 2017-03-22 , DOI: 10.1002/adhm.201770027
Kritee Pant ₁ , Ondřej Sedláček ₂ , Robin A. Nadar ₁ , Martin Hrubý ₂ , Holger Stephan ₁

Affiliation

The utilization of polymeric nanomaterials in combination with imaging‐ and/or therapy‐related radionuclides holds a promising potential for cancer diagnosis and treatment. In article number 1601115, Holger Stephan, Martin Hrubý, and co‐workers review the recent advances and emerging opportunities of tumour‐targeted radiolabelled polymeric nanomaterials for both non‐invasive imaging and treatment of cancer.

中文翻译：

治疗学：用于癌症成像和治疗的放射性标记聚合材料：Qu Vadis？（Adver Healthcare Mater.6 / 2017）

与成像和/或治疗相关的放射性核素结合使用聚合物纳米材料在癌症的诊断和治疗方面具有广阔的前景。Holger Stephan，MartinHrubý和同事在编号1601115中回顾了肿瘤靶向放射标记的聚合物纳米材料在无创成像和癌症治疗中的最新进展和新兴机会。

更新日期：2017-03-22

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南